Samuel
Bozzette (B.S., Georgetown University; M.D., University
of Rochester; Ph.D., RAND Graduate School of Policy Studies) is senior natural
scientist at the RAND Corporation, and adjunct professor of medicine and of international
relations at UC San Diego. He is board-certified
in Internal Medicine and Infectious Diseases, and is a fellow of the American
College of Physicians and the Infectious Diseases Society of America. He is a
member
of the American Society for Clinical Investigation, the Association of American
Physicians, and the Pacific Council on International Policy. He has a strong
record of clinical, translational, outcomes, and health economics research, resulting
in over 150 publications (including more than 20 in the New England Journal
of
Medicine and Journal of the American Medical Association) that
have been cited
by more than 5,000 other publications. Many of these studies significantly
changed clinical practice or policy, as did his seminal work in modeling of potential
bioterrorist
attacks.
Dr Bozzette has served in the leadership of collaborative groups such as
the AIDS Clinical Trials Group (where he was head of the Opportunistic Infections
and later the Outcomes working groups) and has been a principal investigator
for many large multicenter clinical trials and outcomes research projects such
as the nationally representative HIV Cost and Services Utilization Study. He
founded an academic Division of Health Services Research in San Diego, headed
a Center for Research in Patient-Oriented Care, and directed the VA's
national Quality Improvement Research Initiative in HIV as well as sites or
cores for the Southern California Evidence Based Practice Center and the Center
for the Study of Provider Behavior, the San Diego Center for Patient Safety,
and the UCSD Center for AIDS Research.
Bozzette is involved in clinical teaching
and teaching of research methods. He has served on many national
committees, including the DHHS Committee on Clinical Practices for HIV Care,
the VA National Clinical
Guidelines Panel, and Institute of Medicine's Committee on the Ryan
White CARE Act (Data for Research Allocations, Planning, and Evaluation),
and the Committee
on HIV Prevention for Injection Drug Users in High-risk Countries. He has
been an advisor to the pharmaceutical industry, the Centers for Disease Control,
the Food and Drug Administration, and research centers and funders.
Raymond
Clark is project manager for Security Studies and Training at
the University of California Institute on Global Conflict and Cooperation.
Clark manages
diverse research, outreach, and training programs in homeland security,
national security, and biosecurity. A former postdoctoral scholar in molecular
cardiology at UC San Diego, Clark is also a founding board member of
the National Postdoctoral Association and an expert on domestic S&T
workforce policies. An important part of his outreach effort is to build
interest in and promote participation by young scientists (postdocs and
graduate students) in policy-related projects and events. In addition,
he is involved in a variety of projects designed to focus attention on
alternative career pathways for young scientists.
Peter
Cowhey is dean of the Graduate School
of International Relations and Pacific Studies at UC San Diego and is a
past director of IGCC. His major fields of research are international political
economy,
comparative
foreign policy, and international relations theory. In 1994, Cowhey took
leave from UC San Diego to join the Federal Communications Commission. In
1997, he became the chief of the international bureau of the FCC, where he
was in charge of all policy and licensing for international telecommunications
services, including all satellite issues and licensing for the FCC. Prior
to becoming bureau chief he was the commission's senior counselor for International
Economic and Competition Policy.
Cowhey's current research includes the political determinants of foreign
policy, the reorganization of the global communications and information
industries, and the future of foreign trade and investment rules in the
Pacific Rim. His extensive research and writings on international telecommunications
markets and regulation have been supported by such research institutes
as the World Bank, the Council on Foreign Relations, the American Enterprise
Institute, the Brookings Institution, the Markle Foundation, and the Twentieth-Century
Fund. His books include The Problems of Plenty: Energy Policy and International
Politics; When Countries Talk: International Trade in Telecommunications
Services (with J. Aronson); Managing the World Economy: The Consequences
of Corporate Alliances (with J. Aronson); and Structure and Policy
in Japan and United States (co-edited with Mathew McCubbins).
Joseph
Curtis is the director for quality assurance
at the Biomedical Headquarters for the American Red Cross in Washington,
D.C. He is responsible for providing quality assurance oversight to the
headquarters operations that control 45 percent of the U.S. blood supply.
Dr. Curtis participated in the United Nations Monitoring, Verification
and
Inspection Commission (UNMOVIC) training program as a bioweapons inspector
in Vienna, Austria in 2003.
Dr. Curtis' expertise in chem-bio medical defense program management
supported the U.S. Marine Corps System Command in winning the David Packard
Award for Acquisition Excellence in 2002. He participated in a joint research,
development, test, and evaluation program with the Canadian Military to
test and obtain FDA approval for a product to decontaminate human skin
from chemical agents and biological toxins. His knowledge of best business
practices and capability maturity models in systems engineering, project
management, and manufacturing has been used to assist the Marine Corps
to integrate a resuscitative surgical system that has saved the lives of
wounded
fighters in Afghanistan and Iraq. As the chief scientist and senior
systems engineer for the Marine Corps in 2002, he participated in the system
integration team responsible for testing the Joint Biological Agent Identification
and Detection System used by the U.S. military to identify biological weapons.
His work with the military also supported research and procurement programs
to develop vaccines against a variety of known biological agents.
Curtis has supported product development efforts funded by the Congressionally
Directed Medical Research Program to conduct human clinical trials for
anti-fungal therapies. He has also supported product testing using the
FDA's Animal Rule under the Foreign Comparative Test program to evaluate
medical countermeasures against biological and chemical agents.
In 1994, Dr Curtis earned a doctorate in Cell & Developmental Biology
from UC Davis.
Michele
Ginsberg is the chief of the division of Community Epidemiology
for the HHSA San Diego County. Community Epidemiology conducts disease
surveillance, investigation, and intervention on communicable diseases,
emerging infectious diseases, and intentional health threats.
Dr. Ginsberg is an adjunct clinical professor in the departments of Medicine and Family Medicine and adjunct professor in the San Diego State School of Public Health. Dr. Ginsberg has conducted investigations of AIDS/ HIV epidemiology and transmission in diverse populations, Hepatitis A in Mexican-American youth, prevalence of lead poisoning in homeless children, and factors influencing use of health care.
Dr. Michael
Friedman is president and chief executive officer
of City of Hope, a cancer research and treatment institution dedicated to
innovation in basic and clinical biomedical research and delivery of compassionate,
world-class patient care. Dr. Friedman was formerly senior vice president
of research and development, medical and public policy, for Pharmacia Corporation.
In addition, he served as chief medical officer for biomedical preparedness
at the Pharmaceutical Research and Manufacturers of America following the
events of September 11, 2001. Dr. Friedman had previously served as FDA Deputy
Commissioner and was later tapped by the Clinton administration to serve
as acting commissioner of the agency. He helped to streamline the FDA's
review and approval process and provided oversight of evaluations for drugs,
biologics, medical devices, and food ingredients.
In 1983, Dr. Friedman was chief of the Clinical Investigations Branch
of the Division of Cancer Treatment at the National Cancer Institute, and
went
on to become associate director of the division's cancer therapy evaluation
program. Before joining the NCI, Dr. Friedman spent nearly a decade at UC
San Francisco, serving as associate professor of medicine, eventually becoming
interim director of the Cancer Research Institute.
Dr. Friedman has received numerous commendations, including the Surgeon General's
Medallion in 1999. He received his Bachelor of Arts degree magna cum laude
from Tulane University and a Doctorate in Medicine from the University of Texas.
He completed postdoctoral training at Stanford University and the National
Cancer Institute, and is board certified in Internal Medicine and Medical Oncology.
Jerry
R. Gillespie, the director of the Western Institute for Food Safety
and Security, brings to his task expertise in several fields of veterinary
medicine, experience in building effective research teams, and enduring
interest in food safety and defense (protection from intentional or unintentional
harm to the food supply).
Dr. Gillespie earned his Doctor of Veterinary Medicine degree from Oklahoma
State University in 1961, spent a year in veterinary practice, and completed
his doctorate in comparative pathology at UC
Davis in 1965. After a postdoctoral fellowship with the Cardiovascular
Research Institute at the UC San Francisco Medical Center, he joined the
faculty of the UC Davis Schools of Veterinary Medicine and Medicine. Dr.
Gillespie remained at Davis from 1966 until 1985, becoming known for his
applications of heart-lung physiology to the developing field of equine
anesthesiology and exercise physiology. He has published more than 100
original scientific publications contributing internationally to a fuller
understanding of respiratory disease, equine exercise physiology, and food
safety.
In 1985, Dr. Gillespie moved to Kansas State University College of Veterinary
Medicine to become head of the Veterinary Teaching Hospital and Department
of Clinical Sciences. While at the college, Gillespie observed the strong
links between the state and its food agriculture industry and began to
promote research on food animals and food safety. He helped found the Kansas
State University Food Animal Health and Management Center in 1994. The
center's findings on the ecology of food-borne pathogens, the role of wildlife-livestock
interaction in spreading disease to people, and other food-related matters
have led to new recommendations for food safety strategies on the farm.
Dr. Gillespie served as first executive director of the Joint Institute
for Food Safety Research, the White House Office for Science and
Technology, U.S. Department of Agriculture, and U.S. Department
of Health and Human
Services. From 2000 until 2002, he and the institute brought together 20
federal
agencies conducting food safety research and laid the groundwork for further
collaborations with state agencies, private industry groups, and international
partners.
Professional service contributions encompass several national and international
organizations, including the American Veterinary Medical Association, the
Academy of Veterinary Cardiology, the American College of Veterinary Anesthesiologists,
and numerous equine groups. He has also led numerous professional committees
and task forces related to food safety and veterinary education.
Dr. Gillespie's goals for the Western Institute for Food Safety and Security include fostering timely food safety and defense research; applying new knowledge to both plant- and animal-based food products; responding to the public and food industries; and promoting the scientific scrutiny of issues throughout the food-production continuum— from the farm environment to the consumer—that will assure the highest international standards of food safety and quality.
Scott
Horsley is a business correspondent for NPR. He covers general
economic issues with a special emphasis on energy. In 2004, Horsley took
a break from business reporting to cover John Kerry's presidential campaign.
He
also reported from the Pentagon during the Afghan war and the early phases
of the Iraq war.
Before joining NPR in 2001, Horsley was a reporter for KPBS-FM, where he
received numerous honors, including a Public Radio News Directors' award
for coverage of the California energy crisis. He also worked as a reporter
for WUSF-FM in Tampa, Florida, and as a news writer and reporter for commercial
radio stations in Boston and Concord, New Hampshire. Horsley began his professional
career in 1987 as a production assistant for NPR in Washington.
Born and raised in Denver, Colorado, Horsley received a bachelor's degree
from Harvard University and an MBA from San Diego State University. In addition
to his radio work, Horsley can be heard in the classrooms of Darnall elementary
school, where he volunteers as a "Rolling Reader." He lives
in San Diego with his dog, Diego.
Michael
Kalichman is a member of the Division of Neuropathology in the Department
of Pathology and is the director of the UCSD Research Ethics Program. From
1986 through much of the 1990s, his research interests included the toxic
effects of local anesthetics to peripheral nerve and diabetic neuropathy.
He first taught about research ethics in 1988, became the director of the
UCSD Research Ethics Program in 1997, and now teaches multiple courses in
research ethics for UCSD graduate students and postdocs.
Dr. Kalichman has
been an invited participant or speaker at many meetings and workshops,
including: Data
Management in Biomedical Research (Dept. Health and Human Services,
1990); Biomedical Research Integrity in the 1990s (sponsored
by NIH, AAMC, and UCSD, San Diego, 1990); The Responsible Conduct
of Research: A Commitment for all Scientists (PRIM&R, San Diego,
1996); Teaching
Responsible Science (National Academy of Sciences, 1997); Educating
for the Responsible Conduct of Research in the New Millennium (PRIM&R,
Bethesda, 1999); review of a proposed PHS Policy on Instruction in
the Responsible Conduct of Research (Office of Research Integrity,
2000); RCR experts invited to consult with NIH on evaluating the training
grant
RCR requirement (Bethesda, 2003); biosecurity education for biology researchers
(Federation of American Scientists, 2004); and drafting of a code for
the conduct of dual use research (National Science Advisory Board on
Biosecurity,
2006). He is the creator of a Web-based resource to help institutions
develop programs of instruction in the responsible conduct of research
(http://rcrec.org/r)
and leads an NIH-funded project to assess the effectiveness of teaching
research ethics.
Dr. Kalichman is president of a national organization
to promote
responsible conduct of research education, the Responsible Conduct
of Research Education Consortium (RCREC, http://rcrec.org), co-director
and co-founder
of the San Diego Center for Ethics in Science and Technology, and co-chair
of the UCSD Embryonic Stem Cell Research Oversight Committee.
Michael Kleeman is a technology industry strategist whose particular skill is in bridging technical and business issues. For over 30 years he has been involved in the technology industry in engineering, planning, management and advisory roles. He has also worked with a number of start-up firms and been an executive manager in both the consulting and technology industry.
Kleeman is an independent consultant working with major global equipment
manufacturers (HW and SW) and global carriers as well as smaller firms in
the services
and optical products areas. This work is focused on end to end user
experience and commercial opportunities. He is also currently at UCSD
working with the IR/PS and the California Institute of Telecommunications
and Internet Technology (CALIT2) on complex modeling, wireless technology
applications and complex visualization systems. Formerly a vice president
at the Boston Consulting Group, director at Arthur D. Little, and executive
at Sprint, Kleeman has been involved with numerous technology companies
in North America as advisor and executive. He has most recently served as
the co-founder, vice president and chief technical officer of Cometa Networks,
a nationwide 802.11 firm, and before that Aerie Networks, a U.S. nationwide
long-distance fiber optic carrier. He was also the founding CTO of Global
Telesystems Group.
Kleeman holds an M.A. from the Claremont Graduate School. He serves as
the national chair of strategy for the American Red Cross and on the boards
of Equal Access, a not-for-profit
providing digital satellite radio services to developing nations, and the
Marine Mammal Center in Sausalito. He is also on the advisory council for
the San Diego Technology Council. Previously he was a visiting fellow
at UC Berkeley (BRIE), a fellow of the BIOS Institute,
a firm specializing in Complex Adaptive Systems, and he served on the board
of Science Foundation Ireland.
Mark
Kleiman, professor
of policy studies at the UCLA School of Public Policy and Social Research, teaches
methods of policy analysis, political philosophy, and drug abuse and crime
control policy. He is also the chairman of BOTEC
Analysis Corporation, a Cambridge, Massachusetts, firm that conducts policy
analysis and contract research on illicit drugs, crime, and health care.
Previously, he held teaching positions at the John F. Kennedy School of Government
and the University of Rochester.
Professor Kleiman's primary research interests are drug abuse and crime
control, with special attention to illicit markets and the design of deterrent
regimes. His past positions include: director of policy and management analysis
for the Criminal Division of the U.S. Department of Justice, deputy director
for management of the Office of Management and Budget for the City of Boston,
special assistant to Edwin H. Land at Polaroid Corporation, and legislative
assistant to Congressman Les Aspin. He directed a study of the Drug Enforcement
Administration for the Clinton transition team. Currently, he chairs the
drug policy committee of the Federation of American Scientists and edits
its Drug Policy Analysis Bulletin.
Simon
Lazarus counsels and represents companies and associations in
legislative, regulatory and policy matters affecting domestic and international
issues. Based on his experience as a White House staff member and as a
private legal and policy advocate, he has advised a foreign
trademark owner on challenges before Congress and the Executive Branch
to its rights under international trade agreements, represented a foreign-based
developer of pharmaceutical products in connection with matters before
the U.S. Government, and advised a leading provider of online employee
training services to multi-national corporations on compliance with the
European Privacy Directive and the U.S.-EU privacy "Safe Harbor" agreement.
Lazarus
has represented a leading provider of wireless technology on global market
access matters involving trade, competition, telecommunications
and standards policy issues before the White House, Executive Departments,
and Congress. He has also represented a leading global online service
and Internet service provider in connection with security, encryption, and
authentication
issues and a leading foreign-based airline in connection with bilateral
negotiations and regulatory matters affecting alliances and marketing
agreements with U.S.-based airlines. In addition, Lazarus has frequently
represented
industry coalitions and associations, including an association of leading
pharmaceutical manufacturers, an association of leading financial services
companies, and served as general counsel to a coalition comprising the
long distance telecommunications industry in connection with enactment
of the Telecommunications Act of 1996.
Lazarus also served as associate director of the White House domestic policy
staff under President Carter, where he oversaw enactment of major Carter
Administration initiatives, including airline, trucking, and rail deregulation
legislation, ethics in government and civil service reform, and the executive
orders and legislation authorizing review of agency regulations by the Office
of Management and Budget and other offices in the Executive Office of the
President.
Dr. Nicole
Lurie is
senior natural scientist and the Paul O'Neill Alcoa Professor of Health
Policy at the RAND Corporation. She is acting co-director of RAND's Center
for Domestic and International Health Security, with responsibility for public
health. Prior to that, she had a long affiliation with the University of Minnesota
and Hennepin County Medical Center, where she was professor of medicine and
public health, and most recently, medical advisor to the commissioner at the
Minnesota Department of Health. From 1998–2001, she took a leave of absence
to serve as principal deputy assistant secretary of health in the U.S. Department
of Health and Human Services. Among her many responsibilities, she had supervisory
responsibility for the Office of Emergency Preparedness and for the development
of the pandemic influenza plan. Dr. Lurie has a long history in the health
services research field, primarily in the areas of access to and quality of
care, managed care, mental health, prevention, and health disparities.
Over the past three years, Dr. Lurie has worked extensively on issues related
to the public health infrastructure and public health preparedness. She led
a study to assess preparedness of California's public health infrastructure
and to estimate gaps. In addition, she co-directs RAND's work with
the U.S. Department of Health and Human Services to develop and test methods
for assessing various components of public health preparedness.
Dr. Lurie attended college and medical school at the University of Pennsylvania,
and completed her residency and MSPH at UCLA, where she was also a Robert
Wood Johnson Foundation Clinical Scholar. She serves as senior editor for Health
Services Research and has served on editorial boards and as a reviewer
for numerous journals. She has served on the council and was president of
the Society of General Internal Medicine, is currently on the board of directors
for the Academy of Health Services Research, and has served on multiple other
national committees. She is the recipient of numerous awards, including the
AHSR Young Investigator Award, the Nellie Westerman Prize for Research in
Ethics, the Heroine in Health Care Award, and is a member of the Institute
of Medicine.
In addition to her work in health services research and health policy, Dr. Lurie continues to practice clinical medicine in the health care safety net and is the mother of teenaged boys.
Craig
McIntosh specializes in quantitative impact analysis and the development
of credit markets for the poor in Latin America and East Africa. McIntosh
is currently investigating the role of credit bureaus in promoting economic
mobility for the poor in Latin America. He is also analyzing the relationship
between business scale and profitability in destitute economic environments,
and the impact of the use of different affirmative actions measures on student
body composition.
He also has expertise in the political and economic development of East Africa.
McIntosh received his Ph.D. in agricultural economics from UC Berkeley.
Judge Margaret McKeown was appointed to the United States Court of Appeals for the Ninth Circuit by President Clinton and was confirmed by the United States Senate in 1998.
Judge McKeown was
a White House fellow in 1980–1981, serving as special assistant to
the Secretary of the Interior and special assistant at the White House. In
1993, she served
as a Japan Society Leadership fellow. After law school, Judge McKeown joined
the law firm of Perkins Coie and was a partner in the Seattle and Washington,
D.C. offices before joining the bench. Her practice focused on complex litigation,
intellectual property, antitrust and trade regulation. The Seattle-King County
Bar Association honored her with its Outstanding Lawyer of the Year Award
and she was named by the National Law Journal as one of the
"50 Most Influential Women Lawyers"in the United States. She has
received a number of other awards, including the University of Wyoming A&S
Outstanding Alumna, the Georgetown University Law Center Outstanding Alumnae
Award, the
Outstanding Mentor Award from Big Sisters; and the Girl Scouts "Cool
Women"
award.
Judge McKeown serves on the Judicial Conference of the United States Codes
of Conduct Committee. She is a member of the ABA Commission for Revision
of the Model Judicial Code, the American Law Institute, the Advisory Board
of the American Judicature Society, the Welsh chapter of the American Inns
of Court, and is a fellow of the American Bar Foundation. She previously
served as president of the Federal Bar Association of the Western District
of Washington,
a lawyer representative to the Judicial Conference of the Ninth Circuit,
a member of the Ninth Circuit Gender Bias Task Force, co-president of Washington
Women Lawyers, a member of the American Bar Association House of Delegates,
and a trustee of the Seattle-King County Bar Association.
Judge McKeown is an adjunct professor at the University of San Diego Law
School. A frequent participant in legal seminars on litigation, computer
law, and intellectual property, she is widely published in the computer
and trade secrets area and is co-author of "Trial Tactics in
Trade Secret Litigation," Intellectual Property Counseling and
Litigation (Matthew
Bender) and "The Promises of a New World Information Order,"The
Knowledge Economy (Aspen Institute). She is also an author of Business
and Commercial Litigation in Federal Courts (West Group).
Judge McKeown has been active in community and civic affairs and currently
serves on the national board of Volunteers of America. She served for many
years on the national board of the Girl Scouts. She is the past
chair of the White House Fellows Foundation.
Judge McKeown attended the University of Madrid and
graduated Phi Beta Kappa from the University of Wyoming with a B.A. in 1972
and from Georgetown University Law Center with a J.D. in 1975. She received
an honorary doctorate from Georgetown University in 2005.
Stephen
M. Maurer is adjunct associate professor of public policy at UC
Berkeley's Goldman School of Public Policy. He is also director of the information
technology and homeland security program, which provides a focal point for
the school's science, innovation, and security initiatives.
From 1982 to 1996, Maurer practiced high technology and intellectual
property litigation at leading law firms in Arizona and California. Since
1999, he has written and taught extensively on a variety of topics including
database policy, academic/industry relations, patent law, antitrust, and
open source biology. His research has appeared in numerous journals
including Nature, Science and Economica. Maurer
holds a B.A. degree from Yale University and a J.D. in law from Harvard
University.
Maurer's homeland security research focuses on designing efficient incentives
for developing vaccines for bioweapons diseases and other urgently needed
homeland security technologies; promoting grassroots initiatives by scientific
communities to reduce the biosecurity risks associated with basic research;
and analyzing how the new science of synthetic biology is change traditional
biosecurity concerns.
Gregg
O'Ryon has more than 25 years with the American Red Cross as
a professional staff member. O'Ryon is currently the national director
of client services for the Red Cross disaster program. In this capacity
he is responsible
for both the development of the elements of the Red Cross disaster relief
program that are provided to clients affected by disaster as well as
the
national delivery of that assistance during relief operations throughout
the United States and its territories. Shelter, feeding, recovery planning,
individual financial assistance, mental health, and physical health programs
are provided under his direction.
Prior to his position at Red Cross National
Headquarters, O'Ryon has directed the local disaster programs
in three different locations: Dayton, Ohio, Boston, Massachusetts, and
San Francisco, California, as well as serving in a variety of management
positions.
O'Ryon has also administered some of the largest relief operations
in ARC history including serving as deputy director on Hurricane Hugo,
and director for Hurricane Iniki and the Oakland Hills firestorm. In
addition, O'Ryon
is a critical incident response team director and an international response
team member.
Kit
Pogliano is associate professor of biology at UC San Diego. She
received her Ph.D. from the department of microbiology and molecular genetics
at
Harvard Medical School and was a Damon Runyon-Walter Winchell postdoctoral
fellow at Harvard University. She is a recipient of the Searle Scholar
and Beckman Young Investigator awards.
Robert Powell is Robson Professor of Political Science
at UC Berkeley. He is the author of numerous works on international relations,
most recently "The Inefficient Use of Power: Costly Conflict with Complete
Information" (American Political Science Review, 2004) and In
the Shadow of Power: States and Strategies in International Politics (Princeton
U. Press, 1999). Powell's current research focuses on the study of continuing
conflicts throughout the world. He is an expert on the application of
game theory to nuclear deterrence.
Michael Sicilia is
public affairs manager with the California Homeland Security Exercise
and Evaluation
Program. Prior to that he was Deputy Director of Communications for California
Governor Gray Davis, 1999–2003. Among his accomplishments, he oversaw
the redesign of California’s award-winning web portal, MyCalifornia.
He helped devise the communications strategy for the Y2K efforts and
was interim spokesperson for the Department of Water Resources, charged
with purchasing power for near-bankrupt utilities during California’s
energy crisis. He was the governor’s liaison the State Joint Information
Center during the devastation Southern California wildfires of 2003.
An award-winning broadcast journalist, from 1997–99, Sicilia was
state capitol reporter for the California Report, heard on NPR stations
statewide. He also covered the Sacramento region for KCBS-AM, San Francisco
and KFBK-AM, Sacramento. Among the highlights of his Sacramento career
was the coverage of the trial of convicted Unabomber Theodore Kaczynski
for Westwood One radio network.
Sicilia won several Southern California Golden Mike Awards for his spot
news coverage of the Los Angeles riots, as well as political and documentary
reporting for station KCSN-FM, Northridge. He was honored by the Associated
Press and the Radio and Television News Director’s Association
for his coverage of the Polly Klaas Abduction case for KSRO-AM, Santa
Rosa. He won a Society of Professional Journalists Award for his reporting
on the O. J. Simpson murder trial for radio station KFBK-AM, Sacramento.
Sicilia was trained in journalism at California State University
Northridge where he won the prestigious Associated Press Clete Roberts
Scholarship and the William Randolph Hearst Scholarship.
Mark
S. Smolinski, M.D.,
M.P.H., is vice president for the biological programs at the Nuclear
Threat Initiative (NTI) and director of their
Global Health and Security Initiative, where he works to improve
the global public health infrastructure for early detection, surveillance
and response to infectious disease threats. In addition, he is a consultant
to the World Health Organization and developed the curriculum for the
WHO Health Leadership Service through a multi-disciplinary group of experts
from around the globe. Prior to joining NTI, Smolinski was senior program
officer at the Institute of Medicine of the National Academy of Sciences
and study director for Microbial Threats to Health: Emergence, Detection,
and Response.
Smolinski received his medical degree from the University of
Michigan, training in internal medicine at Oakwood Hospital in Dearborn,
Michigan, and training in preventive medicine at the University of
Arizona where he received his Masters in Public Health. He is board certified
in public health and preventive medicine. He was a member
of the
investigation team during the hantavirus discovery in Southwestern
United States in 1993.
Smolinski was stationed as a CDC epidemic intelligence
officer in San Diego, California from 1995–1997, where his experience
included
epidemiologic fieldwork in the Republic of Georgia. From 1997–2000,
he was the ATPM Luther Terry Fellow at the U.S. Department of Health
and
Human Services in the Office of Public Health and Science, where he
was a member of the Healthy People 2010 development team and had primary
responsibility for Healthy People 2010: Understanding and Improving
Health
that focuses on the Leading Health Indicators and a community health
framework.
Samuel
Stanley is a professor in the Division of Infectious Diseases
in the Departments of Medicine and Molecular Microbiology
at Washington University. He is the principal investigator and director
of the multi-institutional Midwest Regional Center of Excellence for
Biodefense
and Emerging Infectious
Diseases Research (MRCE). On July 1, 2006, Dr. Stanley became
vice chancellor for research at Washington University.
Dr. Stanley received
a B.A. from the University of Chicago, and his M.D. from Harvard Medical
School. He joined the faculty of Washington University School of Medicine
in 1987, and has been involved in both basic science research in the
Departments of Medicine and Molecular Microbiology, and patient care
at Barnes Jewish Hospital. Dr. Stanley's research focuses on
the interactions between parasitic and bacterial pathogens and the
human
host, with a special emphasis on innate immunity to gut pathogens.
He also has a long-standing interest in vaccine development and the
immunogenetics
of vaccine responses. He is a former Pfizer post-doctoral fellow, recipient
of a Research Career Development Award from NIH, sits on the NIH Eukaryotic
Pathogenesis Study Section, and is a Burroughs Wellcome Scholar in
Molecular Parasitology.
Jeffrey
Wasserman, Ph.D., is a senior policy researcher at RAND. Wasserman
has more than 25 years of experience directing large and complex health
services research projects in the areas of public health preparedness,
health care financing, and health promotion and disease prevention. He
currently serves as principal investigator or co-principal investigator
on projects related to evaluating the public health system's ability
to prepare for, and respond to, infectious disease outbreaks (including
bioterrorist attacks); measuring the health impact in developing countries
of additional investments in diagnostic technologies; and assessing the
impact of health reform options in the United States. Recently, Wasserman
led projects on financing the health services safety net and on how the
U.S. Department of Veterans Affairs could modify its budget allocation
mechanism to better serve the health care needs of veterans.
Wasserman has published numerous papers and technical reports, as well
as co-authored three books (The Costs of Poor Health Habits, Harvard University
Press;
Tobacco Control Laws: Implementation and Enforcement, RAND; and Combating
Teen Smoking: Research and Policy Findings, University of Michigan
Press). Wasserman received his doctorate in public policy analysis from
the
RAND Graduate School for Policy Studies, where he was a Pew Health Policy
Fellow.
Dr. Cyndi Wells joined the staff of Los Alamos National Laboratory
(LANL) in 2000. She is a technical staff member in the nonproliferation division,
whose
work spans across several divisions at the laboratory. Her work is focused
on nonproliferation of chemical and biological weapons from several different
perspectives,
including informing policy, policy analysis, and intelligence analysis. She
is also keenly interested in improving technology for detection of chemical
weapons and heads a basic technical research project in this area. Wells
is the laboratory appointed representative to both the Biological and
Toxin Weapons Convention and the Chemical Weapons Convention Interlaboratory
Working
Groups
of the Department of Energy. As the LANL representative to these groups,
she
is responsible for the Laboratory's completion of the annual Confidence
Building Measures. In 2003–2004, she was a member of the Iraq Survey
Group's Chemical
Warfare Agent Team, based in Baghdad. The Iraq Survey Group is fact-finding
mission
into the state of the Weapons of Mass Destruction (WMD) programs developed
by Iraq under the regime of Saddam Hussein.
In 1994, Wells received a B.S. with high honors in chemistry and Japanese
from the University of Michigan. In 1999, she received a Ph.D. in physical
chemistry from the University of Texas at Austin. She is an active member
of the search and rescue community, having participated with her tracking
dog on numerous searches as a member of Mountain Canine Corps, and is a
triathlete.
Dean
Wilkening directs the science program at the Center for International
Security and Cooperation at Stanford University. He holds a Ph.D. in physics
from Harvard University and spent thirteen years at the RAND Corporation
prior to coming to Stanford in 1996. His major research interests have
been nuclear
strategy
and policy, arms control, the proliferation of nuclear, biological, and
chemical weapons, ballistic missile defense, and conventional force modernization.
His
most recent research focuses on ballistic missile defense and biological
terrorism. His work on missile defense focuses on the broad strategic and
political implications
of deploying national and theater missile defenses, in particular, the
impact of theater missile defense in Northeast Asia, and the technical
feasibility
of boost-phase interceptors for national and theater missile defense. His
work on biological weapons focuses on understanding the scientific and
technical
uncertainties associated with predicting the outcome of hypothetical airborne
biological weapon attacks, with the aim of devising more effective civil
defenses, and a reanalysis of the accidental anthrax release in 1979 from
a Russian military
compound in Sverdlovsk with the aim of improving our understanding of the
human effects of inhalation anthrax.
After graduating from California State University at Northridge with
a B.A. in biology, and from University of Stockholm with a Filosofie Kandidat
in organic chemistry, Dr. Raymond Zilinskas worked as a
clinical microbiologist for sixteen years, then commenced graduate studies
at the
University of Southern California. His dissertation addressed policy issues
generated
by recombinant DNA research, including the applicability of genetic engineering
techniques for military and terrorist purposes. After earning a Ph.D.,
Dr. Zilinskas
worked at the U.S. Office of Technology Assessment (1981–1982), United
Nations Industrial Development Organization (1982–1986), and University
of Maryland Biotechnology Institute (UMBI) (1987–1998). In addition, he
was an adjunct associate professor at the Department of International Health,
School of
Hygiene and Public
Health, Johns Hopkins University, until 1999.
In 1993, Dr. Zilinskas was appointed William Foster Fellow at the U.S.
Arms Control and Disarmament Agency (ACDA), where he worked on biological
and toxin warfare issues. In 1994, ACDA seconded Dr. Zilinskas to the United
Nations Special Commission (UNSCOM), where he worked as a biological analyst
for seven months. He participated in two biological warfare-related inspections
in Iraq (June and October 1994) encompassing 61 biological research and
production facilities. He set up a database containing data about key dual-use
biological equipment in Iraq and developed a protocol for UNSCOM's ongoing
monitoring and verification program in the biological field.
After the fellowship, Dr. Zilinskas returned to the UMBI and Johns Hopkins
University. In addition, he continued to serve as a long-term consultant
to ACDA (now part of the U.S. Department of State), for which he carried
out studies on Cuban allegations of U.S. biological attacks against its
people, animals, and plants; and investigations carried out by the United
Nations of chemical warfare in Southeast Asia and the Arabian Gulf region.
Dr. Zilinskas also is a consultant to the U.S. Department of Defense.
In September 1998, Dr. Zilinskas was appointed senior scientist at the
Center for Nonproliferation Studies (CNS), Monterey Institute of International
Studies. In 2002, he became director of the Chemical
and Biological Weapons Nonproliferation Program at the CNS. His research
focuses on achieving effective biological arms control, assessing the proliferation
potential of the former Soviet Union's biological warfare program,
and meeting the threat of bioterrorism. Dr. Zilinskas' book Biological
Warfare: Modern Offense and Defense, a definitive account of how modern
biotechnology has qualitatively changed developments related to biological
weapons and defense, was published in 1999. His co-edited book Encyclopedia
of Bioterrorism Defense was
published by Wiley in 2005, and currently he is writing a book on
the former Soviet Union's biological warfare program, including its
history, organization, accomplishments, and proliferation potential, which
will be published in 2007.
